Moolec Science SA

Finanzas de Moolec Science SA (MLEC)

$6.800

-0.059 (-0.87%)Al cierre

Rentabilidad y márgenes de MLEC

Evaluating the bottom line, Moolec Science SA maintains a gross margin of -25.78%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -77.92%, while the net margin is -91.84%. These profitability ratios, combined with a Return on Equity (ROE) of -174.68%, provide a clear picture of how effectively MLEC converts its operational activities into shareholder value.

Comparativa sectorial de MLEC

In the context of the broader market, MLEC competes directly with industry leaders such as TGL and EEIQ. With a market capitalization of $14.17M, it holds a leading position in the sector. When comparing efficiency, MLEC's gross margin of -25.78% stands against TGL's 0.43% and EEIQ's 57.92%. Such benchmarking helps identify whether Moolec Science SA is trading at a premium or discount relative to its financial performance.

Desempeño financiero de Moolec Science SA

Moolec's financial performance shows troubling signs, with a gross margin of -25.78% in Q2 2025 and a net margin of -91.84%. The company has been operating at a loss, with net income of -2,427,307 USD in Q2 2025.

Financials

FY2025Q2
YoY:
+948.32%
2.64M
Total Revenue
FY2025Q2
YoY:
+14.86%
-2.06M
Operating Profit
FY2025Q2
YoY:
+36.10%
-2.43M
Net Income after Tax
FY2025Q2
YoY:
+32.06%
-9.35
EPS - Diluted
FY2025Q2
YoY:
-65.39%
-1.41M
Free Cash Flow
FY2025Q2
YoY:
-133.20%
-25.78
Gross Profit Margin - %
FY2025Q2
YoY:
-80.49%
-87.44
FCF Margin - %
FY2025Q2
YoY:
-87.02%
-91.84
Net Margin - %

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empieza gratis